文献速递头颈部肿瘤放疗放疗物理与技术

多参数PET/MRI一站式头颈癌放疗计划制定的可行性

Feasibility of Multiparametric Positron Emission Tomography/Magnetic Resonance Imaging as a One-Stop Shop for Radiation Therapy Planning for Patients with Head and Neck Cancer.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2020-07-16

本研究纳入11例头颈部癌患者,在放疗治疗体位下完成多参数PET/MRI检查,并用卷积神经网络由Dixon MRI生成合成CT(sCT)。除1例带气管造瘘管患者外,基于sCT的剂量参数与CT计划差异在±1%以内;PET的SUVmean与SUVmax平均差异分别为0.4±1.2%和-0.5±1.0%,提示该流程临床可行。

要点

  • 头颈癌患者在放疗体位下完成多参数PET/MRI检查临床可行。
  • 深度学习由MRI生成的sCT可用于剂量计算和PET衰减校正。
  • 除带气管造瘘管者外,sCT计划剂量参数与CT计划差异在±1%以内。

核心结论

  • 头颈癌患者在放疗体位下行多参数PET/MRI临床可行,sCT用于PET衰减校正和剂量计算精度足以满足临床使用,是迈向多参数PET/MRI一站式个体化放疗计划的重要一步。

研究设计与样本

  • 单中心可行性研究,纳入11例头颈癌患者(含3例预试验患者),均在常规FDG-PET/CT计划扫描后于放疗治疗体位行PET/MRI,扫描方案包含多参数成像。
  • 采用留一法训练卷积神经网络,由Dixon MRI预测sCT,并将临床CT剂量计划在sCT上重新计算后比较剂量差异。
  • 比较基于sCT衰减校正与基于CT衰减校正的PET,评估PET阳性体积的SUVmean与SUVmax相对差异。

主要发现

  • 11例患者均完成放疗治疗体位的PET/MRI检查;除3例预试验患者外,8例中7例在45分钟内完成完整多参数成像,1例在30分钟后终止检查。
  • 除1例置入气管造瘘管的患者外,sCT计划的全部剂量学参数与CT计划的差异均在±1%以内。
  • PET方面,SUVmean平均差异为0.4±1.2%,SUVmax平均差异为-0.5±1.0%。

关键数值与推荐

  • 剂量学比较指标为不同感兴趣体积的平均、最大、近最大和近最小吸收剂量的相对差异。
  • PET比较指标为PET阳性体积的SUVmean与SUVmax相对差异,SUVmean平均差异0.4±1.2%,SUVmax平均差异-0.5±1.0%。

临床怎么用

  • 提示可在放疗治疗体位下整合多参数PET/MRI并生成sCT,用于剂量计算与PET衰减校正,为仅基于PET/MRI制定放疗计划提供依据。
  • 对置入气管造瘘管的患者,sCT剂量准确性可能受影响,需谨慎对待。

局限性

  • 样本量仅11例,含3例预试验患者;1例因故提前终止检查;1例带气管造瘘管患者剂量参数超出±1%范围。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Multiparametric positron emission tomography (PET)/magnetic resonance imaging (MRI) as a one-stop shop for radiation therapy (RT) planning has great potential but is technically challenging. We studied the feasibility of performing multiparametric PET/MRI of patients with head and neck cancer (HNC) in RT treatment position. As a step toward planning RT based solely on PET/MRI, a deep learning approach was employed to generate synthetic computed tomography (sCT) from MRI. This was subsequently evaluated for dose calculation and PET attenuation correction (AC). METHODS AND MATERIALS: Eleven patients, including 3 pilot patients referred for RT of HNC, underwent PET/MRI in treatment position after a routine fluorodeoxyglucose-PET/CT planning scan. The PET/MRI scan protocol included multiparametric imaging. A convolutional neural network was trained in a leave-one-out process to predict sCT from the Dixon MRI. The clinical CT-based dose plans were recalculated on sCT, and the plans were compared in terms of relative differences in mean, maximum, near-maximum, and near-minimum absorbed doses for different volumes of interest. Comparisons between PET with sCT-based AC and PET with CT-based AC were assessed based on the relative differences in mean and maximum standardized uptake values (SUVmean and SUVmax) from the PET-positive volumes. RESULTS: All 11 patients underwent PET/MRI in RT treatment position. Apart from the 3 pilots, full multiparametric imaging was completed in 45 minutes for 7 out of 8 patients. One patient terminated the examination after 30 minutes. With the exception of 1 patient with an inserted tracheostomy tube, all dosimetric parameters of the sCT-based dose plans were within ±1% of the CT-based dose plans. For PET, the mean difference was 0.4 ± 1.2% for SUVmean and -0.5 ± 1.0% for SUVmax. CONCLUSIONS: Performing multiparametric PET/MRI of patients with HNC in RT treatment position was clinically feasible. The sCT generation resulted in AC of PET and dose calculations sufficiently accurate for clinical use. These results are an important step toward using multiparametric PET/MRI as a one-stop shop for personalized RT planning.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Olin AB, Hansen AE, Rasmussen JH, et al. Feasibility of Multiparametric Positron Emission Tomography/Magnetic Resonance Imaging as a One-Stop Shop for Radiation Therapy Planning for Patients with Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2020. PMID: 32682955. doi:10.1016/j.ijrobp.2020.07.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。